title: Comparison of treatment regimes for lupus nephritis.
abstract: The best therapeutic choice in the treatment of lupus nephritis remains open to debate. In addition, there have been little data on the treatment of lupus nephritis in Asian patients. The objective of this study was to look at the response rate and complications of treatment given for lupus nephritis in a group of South East Asian patients with systemic lupus erythematosus (SLE). This was a retrospective, cross-sectional study of 103 patients with lupus nephritis. Detailed analysis was done on 58 patients with Class IV disease. The median time to remission was 12.1 months for azathioprine (AZA), 15.01 months for oral cyclophosphamide (CPM) and 15.25 months for intravenous (i.v.) CPM. The percentage of patients achieving remission after the first course of treatment was 42.9% with AZA, 83.3% with oral CPM and 90.9% with i.v. CPM. Overall, 41/58 (70.7%) of patients went into remission following the first course of treatment. Seventeen (41.5%) subsequently relapsed, requiring a second course of treatment. Fifty-two (50.5%) of all patients had drug-related complications from their treatment. The most frequent complication for the group was amenorrhoea (23.3% of all patients, 40% of those who had CPM previously), which was significantly more frequent in patients given CPM. In conclusion, more patients achieve remission when treated with CPM compared with AZA alone but this is associated with a higher complication rate, especially amenorrhoea.
authors.affiliation: Department of Medicine, University of Malaya, Kuala Lumpur.
authors.forename: S S
authors.initials: SS
authors.lastname: Yeap
authors.forename: S I
authors.initials: SI
authors.lastname: Asarudin
authors.forename: S K
authors.initials: SK
authors.lastname: Chow
authors.forename: C T
authors.initials: CT
authors.lastname: Chua
authors.forename: L C
authors.initials: LC
authors.lastname: Lai
mesh_terms: D000328:Adult; D005006:Ethnicity / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008181:Lupus Nephritis / Q000208:ethnology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged